In the second study, whose objective was the molecular analysis of the BRCA genes in 190 patients with triple negative breast cancer diagnosed before the age of 50 years, the 9–12 of the BRCA1 accounted for 41% of mutations identified [16]. Here, BRCA1 is linked to triple-negative breast carcinoma.